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Abstract 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD; diox-
in), a member of a class of environmental pollutants represented
by polychlorinated dibenzo-p-dioxins and dibenzofurans, is one
of the most toxic artificial compounds ever developed. In this
study, we identified a novel TCDD target gene, DIF-3 (dioxin
inducible factor-3), by cDNA representational difference analy-
sis. DIF-3 protein is a nuclear factor and possesses a zinc-finger
motif at its N-terminus. High DIF-3 mRNA expression in the
testes was demonstrated by Northern blot analysis and abundant
DIF-3 protein was detected during spermatogenesis. Thus, these
results suggest that DIF-3 may be a target gene mediating the
reproductive toxicity induced by TCDD. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
In recent years, several reports have focused on certain
man-made toxins known as endocrine disrupting chemicals
(EDCs) that persist in the environment and are capable of
altering the endocrine homeostasis of an animal, thereby caus-
ing serious reproductive and developmental defects [1,2]. One
such compound is the xenobiotic agent 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD; dioxin). It is one of the most potent
members of a family of EDCs, the polyhalogenated aromatic
hydrocarbons. Exposure to TCDD induces transcriptional ac-
tivation of genes encoding xenobiotic metabolizing enzymes
including cytochromes P450 (CYP1A1, CYP1A2, CYP1B1)
and phase II enzymes such as UDP-glucuronyl-S-transferases
and sulfotransferases [3,4]. Changes in gene expression in-
duced by TCDD and related chemicals are initiated upon
their binding to the aryl hydrocarbon receptor (AhR), which
then dimerizes with the AhR nuclear translocator, forming a
complex which interacts with gene regulatory elements,
known as xenobiotic response element motifs [3,4].
TCDD exposure can result in carcinogenesis, immunosup-
pression, and tissue and organ toxicity, as well as developmen-
tal toxicity and teratogenesis, when administered prenatally
[5]. Alterations in gene expression that result from TCDD
exposure are thought to contribute to the mechanisms under-
lying many of the e¡ects induced by this compound. Studies
with AhR-de¢cient mice revealed TCDD-induced tissue spe-
ci¢c toxicity and transcriptional activation of genes encoding
xenobiotic metabolizing enzymes to be mediated by AhR [6^
8]. Although the AhR mediates many of the TCDD-induced
changes in gene expression, the putative target genes respon-
sible for toxicity have yet to be identi¢ed. Moreover, we have
described the AhR-independent gene suppression by TCDD
[9], and it is suggested that AhR-independent mechanisms
may contribute to TCDD-induced developmental toxicity
[10]. Clearly, the precise molecular mechanisms underlying
TCDD toxicity in humans are still essentially unknown.
Based on these previous ¢ndings, we attempted to identify
TCDD target genes using mouse embryonic stem (ES) cells.
The identi¢cation of such downstream genes should shed light
on the molecular mechanisms underlying EDC toxicity.
2. Materials and methods
2.1. Cell culture
TT2 ES cells were provided by Dr. Tetsu Akiyama (The University
of Tokyo, Tokyo, Japan). TT2 ES cells were maintained as previously
described [11].
AhR3=3 embryos were generated from intercrossed AhR=3 mice
[6]. Mouse embryonic ¢broblasts (MEFs) with wild-type or mutant
genotypes were generated from day 14.5 mouse embryos [11]. HeLa
cells and MEFs were grown as previously described [9].
2.2. Chemicals
TCDD (Cambridge Isotope Laboratories, Inc., Andover, MA,
USA) was prepared in dimethylsulfoxide (DMSO).
2.3. cDNA synthesis and representational di¡erence analysis (RDA)
All procedures were performed as described previously [12,13]. ES
cells at V80% con£uence were treated with 0.1% DMSO alone or
with 1 WM TCDD by the exchange of the conditioned maintenance
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media for fresh media containing these chemicals. After 4 h treatment,
the cells were harvested. Poly(A)+RNA was prepared from the ES
cells and double-stranded cDNA synthesis was performed using a
TaKaRa cDNA synthesis kit (TaKaRa, Tokyo, Japan). In the ¢rst
and second rounds of subtractive hybridization, tester:driver ratios of
1:100 and 1:800 respectively, were used. After two cycles of subtrac-
tion and ampli¢cation, the di¡erential products were subcloned into a
pGEM-3Z vector (Promega, Madison, WI, USA). The cloned cDNA
fragments were then sequenced and used as probes for Northern blot
analysis.
2.4. RNA isolation, Northern blot and RT-PCR analysis
For cDNA synthesis and Northern blot analysis, total RNA from
ES cells and MEFs was prepared as previously described [9]. The
dioxin inducible factor-3 (DIF-3) cDNA fragments (nucleotides
1152^2416) were used as probes. Northern blot analysis was per-
formed as previously described [9].
To obtain the murine DIF-3 cDNA fragment, we performed RT-
PCR using total RNA from ES cells. The nucleotide sequences of the
primers used were as follows: DIF-3 primer 1S, CCCA-
CACTCCCCGTGGCGCGAGCGGCTG; and DIF-3 primer 2AS,
GCCACTAAGTTGCTTTAGTAGTCTC. The ampli¢ed sequences
were cloned into a pGEM-T easy vector (Promega, Madison, WI,
USA).
2.5. Preparation of antiserum, Western blot analysis, indirect
immuno£uorescence staining and immunohistochemical analysis
To generate antiserum against DIF-3, cDNA containing the entire
DIF-3 open reading frame was inserted into the Escherichia coli ex-
pression vector pET3a (Stratagene, La Jolla, CA, USA) at the EcoRI
site and transformed into the BL21(DE3)pLysS strain of E. coli. The
expression of recombinant DIF-3 linked to a 6U histidine tag at the
N-terminus was induced by treatment of the bacterial culture with
IPTG. Soluble recombinant protein was puri¢ed with a HisTrap kit
(Amersham Pharmacia Biotech, Uppsala, Sweden) according to the
manufacturer’s protocol. Rabbits were immunized with puri¢ed DIF-
3 and antiserum was developed.
Immunoblotting was performed as previously described [9]. The
nuclear and cytoplasmic fractions of HeLa cells were prepared as
previously described [14]. Membranes were probed with the DIF-3
antiserum at a dilution of 1:1000. Pre-immune serum was used for
control experiments. The signals were detected with an ECL plus
Western blotting detection system (Amersham Pharmacia Biotech,
UK).
The details of the cell staining procedure were as previously de-
scribed [15]. The cells were stained with the DIF-3 antiserum at a
dilution of 1:100.
To obtain frozen sections of the testis, excised mouse testes were
Fig. 1. TCDD treatment induced DIF-3 expression in ES cells and
MEFs. A: Northern blot analysis of total RNA from ES cells. ES
cells were treated with 0.1% DMSO alone or with 1 WM TCDD for
2 h. An arrow indicates the DIF-3 signal. An ethidium bromide-
stained gel is shown as control. B: Northern blot analysis of the
dose-dependent induction of DIF-3 by TCDD. ES cells were treated
with 0.1% DMSO and TCDD (0, 1, 10, 100, 1000 nM each) for 2 h.
An arrow indicates the DIF-3 signal. An ethidium bromide-stained
gel is shown as control. C: DIF-3 induction by TCDD mediated by
an AhR-dependent pathway. Northern blot analysis demonstrates
that DIF-3 mRNA is not induced in AhR3=3 MEFs treated with
0.1% DMSO alone or with 100 nM TCDD for 6 h. On the other
hand, DIF-3 is activated by TCDD in AhR= MEFs treated with
0.1% DMSO alone or with 100 nM TCDD for 6 h. An arrow indi-
cates the DIF-3 signal. The L-actin signals were also shown to con-
¢rm the induction of DIF-3 mRNAs.
Fig. 3. DIF-3 expressed in the nucleus. A: Western blot analysis of
the cytoplasm and nuclear fractions from HeLa cells. An arrow in-
dicates the DIF-3 signal. No signal was detected using pre-immune
serum (data not shown). B: DIF-3 immunostaining of ¢xed HeLa
cells. DIF-3 protein localized in the nucleus. Nuclear morphology of
the same cells stained with the DNA-binding dye H33258. No signal
was detected using pre-immune serum (data not shown).
Fig. 2. The predicted domain structure of mouse DIF-3 is depicted
in cartoon form. The nucleotide sequence of the cDNA has been
deposited in DDBJ/EMBL/GenBank database under accession num-
ber AB064543.
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embedded with an optical cutting temperature compound (Sakura
Finetechnical Co., Ltd., Tokyo, Japan) and frozen rapidly with etha-
nol/dry ice. Testicular slices were prepared and ¢xed with 4% para-
formaldehyde phosphate-bu¡ered saline for 10 min. Immunostaining
was performed with the DIF-3 antiserum at a dilution of 1:100. Con-
trol staining was performed using an equivalent concentration of pre-
immune rabbit serum.
To make para⁄n sections, excised mouse testes were ¢xed with 4%
paraformaldehyde, embedded in para⁄n, and sliced into 5-Wm sec-
tions. The sections were incubated with DIF-3 antiserum at a dilution
of 1:100 for 1 h. An LSABC kit (Dako Japan, Kyoto, Japan) was
used as the detection system and 3,3P-diaminobenzidine as a chrom-
ogen. Hematoxyline was used for counterstaining.
3. Results and discussion
To isolate genes induced by TCDD, we performed RDA of
cDNA derived from ES cells treated with TCDD and com-
pared the results with those from untreated ES cells. Two
cycles of RDA yielded several distinct bands on a 2% agarose
gel. DNA fragments corresponding to these bands were sub-
cloned and used as probes for Northern blots prepared from
TCDD-treated or untreated ES cells. This procedure led to
the identi¢cation of several unique genes that were overex-
pressed in TCDD-treated cells. One cDNA clone exhibiting
particularly strong di¡erential expression corresponded to a
novel gene termed DIF-3 (Fig. 1A). Next, we examined the
TCDD dose-dependency of DIF-3 expression. ES cells were
treated for 2 h with several concentrations of TCDD. Fig. 1B
shows that DIF-3 was indeed dose-dependently induced by
TCDD.
The e¡ects of TCDD are reportedly mediated by the AhR
[4,6^8]. To determine the involvement of the AhR-mediated
pathway in the TCDD-mediated induction of DIF-3, we ex-
amined DIF-3 expression in AhR-de¢cient (AhR3=3) MEFs
treated with 100 nM TCDD for 6 h by Northern blot analysis.
DIF-3 induction was not detected in AhR3=3 MEFs (Fig.
1C), indicating that DIF-3 expression following TCDD treat-
ment is mediated by an AhR-dependent pathway.
To obtain the full-length murine DIF-3 cDNA, we searched
the expressed sequence tag (EST) database. The 2711-nucleo-
tide-long mouse DIF-3 cDNA was then ampli¢ed by RT-PCR
using primers based upon EST clones AI 788249 and BE
985276 from mouse testicular cDNA. Examination of the
Fig. 4. DIF-3 expressed in mouse testis. A: Total RNA from the indicated organs of adult mice were hybridized with DIF-3 cDNA. An arrow
indicates the DIF-3 signal. An ethidium bromide-stained gel is shown as control. B: Proteins from the indicated organs of adult mice were in-
cubated with anti-DIF-3 antibody. An arrow indicates the DIF-3 signal. C: DIF-3 indirect immuno£uorescence staining in testes. Frozen sec-
tions of adult mice (panels 1 and 2) and newborn mice (panels 3 and 4) were reacted with anti-DIF-3 antibody, and visualized with Alexa 488-
labeled rabbit IgG antibody. Tissues were stained with DNA-binding dye H33258 to reveal the presence of cells with condensed chromatin. D:
Formalin-¢xed and para⁄n-embedded sections of adult testes were reacted with anti-DIF-3 antibody. The signals were visualized with diamino-
benzidine and counterstained with hematoxylin (panels 1 and 2). Speci¢c cell types in the seminiferous epithelium are identi¢ed: arrowhead, pa-
chytene spermatocyte; double arrowhead, Sertoli’s cell ; asterisk, round spermatid (panel 2). No signal was detected when pre-immune serum
was used instead of anti DIF-3 antibody as control (data not shown).
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cDNA sequence revealed that it encodes a protein of 741
amino acids with a C2H2 zinc-¢nger domain (residues 259^
301), two basic regions (residues 417^429, 573^587) and three
repeated acidic regions (residues 398^416, 551^569, 672^691)
(Fig. 2). The complete sequence data have been deposited into
the DDBJ/EMBL/GenBank database under accession number
AB064543. From these results, we predicted DIF-3 to be a
nuclear factor. To con¢rm the localization of DIF-3, we made
a polyclonal antibody against recombinant DIF-3 protein.
DIF-3 protein was detected in the nuclear fraction from
HeLa cells as an V80 kDa protein. The molecular weight is
coincided with the calculated molecular weight, 84 kDa, of
mouse DIF-3 protein. On the other hand, the cytoplasmic
fraction was negative for DIF-3 protein by Western blot anal-
ysis (Fig. 3A). Staining of ¢xed HeLa cells with the DIF-3
antibody revealed the presence of reactive antigen in the nu-
cleus (Fig. 3B).
Northern and Western blot analysis of normal mouse tis-
sues revealed the DIF-3 mRNA and protein were detected
only in the testis (Fig. 4A,B). Indirect immuno£uorescence
staining revealed DIF-3 to be abundantly expressed during
spermatogenesis (Fig. 4C). In newborn animals, in which sper-
matogenesis has not yet progressed beyond the earliest stages,
DIF-3 was not detectable (Fig. 4C). These results indicate that
DIF-3 may not be involved in initial testicular development.
Finally, to examine DIF-3 expression in more detail, immu-
nohistochemical analyses were performed using para⁄n sec-
tions. DIF-3 is expressed most strongly in the large pachytene
spermatocytes, which are distinguished by their size and loose
chromatin organization (Fig. 4D, arrowhead). DIF-3 immu-
noreactivity was also present in the round spermatids (Fig.
4D, asterisk) but was undetectable in condensing forms of
sperm. Spermatogonia and Sertoli cells exhibited only back-
ground levels of staining.
What is the physiological function of DIF-3? Sequence
analysis revealed that DIF-3 has a C2H2 zinc-¢nger motif,
two basic regions and three repeated acidic regions, suggesting
that DIF-3 may bind to DNA and act as a transcriptional
modulator. Immunohistochemical analysis showed DIF-3 to
be localized in the nuclei of mouse testicular cells. Northern
blot analysis of normal tissues showed that DIF-3 mRNA is
abundantly expressed in the testis. Furthermore, DIF-3 pro-
tein was detected during spermatogenesis in adult, but not
neonatal, testes. In addition, DIF-3 was immunohistochemi-
cally shown to be strongly expressed in pachytene spermato-
cytes. Although further study is required to clarify these is-
sues, DIF-3 is anticipated to play an important role in
transcriptional regulation of meiotic events during spermato-
genesis.
In recent years, several reports have focused on certain
man-made toxins known as EDCs that persist in the environ-
ment and are capable of altering the endocrine homeostasis of
an animal, thereby causing serious reproductive and develop-
mental defects, as well as testicular oncogenesis [1,2,16]. Sev-
eral reports have also provided evidence of a decline in semen
quality and/or sperm counts over the same period ([16] and
references therein). Among various EDCs, TCDD and estro-
genic chemicals such as diethylstilbestrol have been demon-
strated to possess the greatest reproductive toxicity [17^19].
Fetal and/or neonatal exposure to these chemicals is especially
problematic [16,20^22]. However, which types of molecules
mediate the toxicity induced by TCDD during spermatogen-
esis remains unclear. Although more experiments are needed
to provide direct evidence linking DIF-3 with TCDD-induced
reproductive toxicity, DIF-3 might be involved with TCDD-
induced reproductive toxicity by interfering with spermato-
genesis.
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